Biogen Idec - Database of Clinical Trials by Pharmaceutical Companies

Paid Clinical Trials and Focus Groups by Category

Find Paid Clinical Trials

Find Paid Clinical Trials All Categories ... Pharma Companies » ... Biogen Idec


  • JCV Antibody Program (STRATIFY-2)

    Condition:   Multiple Sclerosis
    Intervention:  
    Sponsors:   Biogen Idec;   Elan Pharmaceuticals
    Not yet recruiting - verified February 2010
  • Natalizumab Treatment of Progressive Multiple Sclerosis

    Conditions:   Primary Progressive Multiple Sclerosis;   Secondary Progressive Multiple Sclerosis
    Intervention:   Drug: Natalizumab
    Sponsors:   Rigshospitalet, Denmark;   Danish Research Centre for Magnetic Resonance, Copenhagen University Hospital Hvidovre;   Biogen Idec;   GCP-unit, Copenhagen University Hospital Bispebjerg;   Signifikans ApS
    Recruiting - verified February 2010
  • JCV Antibody Program

    Condition:   Multiple Sclerosis
    Intervention:  
    Sponsors:   Biogen Idec;   Elan Pharmaceuticals
    Not yet recruiting - verified February 2010
  • Treatment Interruption of Natalizumab

    Condition:   Relapsing Remitting Multiple Sclerosis
    Interventions:   Drug: natalizumab;   Drug: interferon beta 1-a;   Drug: methylprednisolone;   Other: IV placebo;   Drug: glatiramer acetate
    Sponsors:   Biogen Idec;   Elan Pharmaceuticals
    Not yet recruiting - verified February 2010
  • Tysabri Effects on Cognition and Neurodegeneration in Multiple Sclerosis

    Condition:   Multiple Sclerosis
    Intervention:   Drug: Tysabri
    Sponsors:   University of Chicago;   Biogen Idec
    Not yet recruiting - verified February 2010
  • Pharmacokinetic, Immunological and Biochemical Sample Collection and Analysis of a Tysabri Patient Cohort

    Condition:   Multiple Sclerosis, Relapsing Forms
    Intervention:  
    Sponsors:   Rocky Mountain Multiple Sclerosis Clinic;   Biogen Idec
    Enrolling by invitation - verified February 2010

Main Menu

Find Clinical Trials